Search Results 101-110 of 16989 for ulcerative%20colitis

1. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis ... ulcerative colitis (UC) in ...

2. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   ... ulcerative colitis or Crohn's disease. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

3. A Study to Evaluate the Safety and Effectiveness of BMS-986165 in Subjects with Moderate-to-Severe Ulcerative Colitis (UC) - Mayo Clinic

   The purpose of this study is to assess the effectiveness and safety of BMS-986165 in ulcerative colitis. Participation eligibility. Participant eligibility ...

4. A Study to Evaluate the Safety, Tolerability and Microbiome Dynamics of SER-287 in Subjects with Ulcerative Colitis - Mayo Clinic

   The purpose of this study is to evaluate the safety, tolerability and microbiome dynamics of SER-287 in subjects with mild-to-moderate ulcerative colitis.

5. A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001) - Mayo Clinic

   A Study To Evaluate Efficacy And Safety Of Tulisokibart (MK-7240) In Participants With Moderately To Severely Active Ulcerative Colitis (MK-7240-001).

6. The role of capsule endoscopy in diagnosis and management of inflammatory bowel disease - Mayo Clinic

   What role can CE play in diagnosing and managing UC? While small bowel CE has been fairly well studied in CD , colon capsule endoscopy (CCE) for ulcerative ...

7. Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC) - Mayo Clinic

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

8. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) · More about research at Mayo ...

9. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

   A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative ...

10. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative Colitis ... ulcerative colitis (UC).